Company Overview
Blackswan Space is a Lithuania-based space technology company focused on engineering services and platform solutions for satellite systems and defense applications. Operating in a market with limited domestic competition, the firm targets cost-sensitive integrators seeking EU-based talent amid expanding ESA and NATO procurement. With revenue below €10M and a growth equity round of €2.6M, the company remains early-stage, likely pre-profit and dependent on project-based contracts rather than recurring platform revenue.
Deal Context
The €2.6M growth equity round positions Blackswan as a candidate for strategic rather than pure financial sponsorship. Defense primes and satellite operators active in NATO supply chains represent the most plausible investors, drawn by Lithuania’s NATO membership, low engineering costs, and scarcity of comparable EU platforms. Founder-led execution and limited local M&A precedents suggest the round is primarily about scaling capacity ahead of larger ESA/NATO tenders rather than an immediate exit.
Valuation Context
Baltic listed peers trade between 5.0x and 15.0x EV/EBITDA, with a cluster around 7–9x for more stable cash-flow names. These multiples serve as an upper bound given sector mismatch and higher liquidity. Applying a 40–60% private-company discount and adjusting for negative EBITDA yields a realistic 3–5x revenue multiple for Blackswan, equating to an €8–15M post-money valuation on current scale. Space-tech scarcity could stretch this toward 6–7x revenue only with proven contract backlog and NATO security clearances.
Triage Verdict
GO
- Fit: Strong sector tailwinds from ESA/NATO budgets, low-cost Baltic engineering base, and zero direct listed comparables in the region.
- Red flags: Likely negative EBITDA, thin public track record, and concentrated customer or project risk typical of sub-€10M space services firms.
- Next step: Request detailed backlog, margin bridge, and customer concentration data; pursue co-investment with a specialist aerospace fund to mitigate single-name exposure.
Key Risk
Dependence on a narrow set of defense or ESA contracts whose timing or award can shift materially with budget cycles or geopolitical priorities.
Bottom line: High strategic scarcity justifies selective pursuit, but only with rigorous backlog verification.
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Merck & Co., Inc. | $625.7B | +197.2% | 26 |
| 2 | Ma Investment Partnership, LP | $322.6B | +181.4% | 18 |
| 3 | Graticule Asia Macro Advisors LLC | $1.1T | +174.1% | 4 |
| 4 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +167.3% | 10 |
| 5 | Anther Capital Ltd | $3.8T | +153.2% | 31 |
| 6 | Step Capital Management Pte. Ltd. | $467.4B | +152.3% | 53 |
| 7 | Theleme Partners LLP | $3.0T | +130.5% | 20 |
| 8 | Central Asset Investments & Manag… | $261.4B | +130.4% | 63 |
| 9 | Oxbow Capital Management (HK) Ltd | $731.4B | +124.8% | 14 |
| 10 | Elemental Capital Partners LLC | $422.8B | +122.3% | 18 |
| Security | Value | Weight |
|---|---|---|
| SANDISK CORP | $565.2B | 28.4% |
| CORNING INC | $408.3B | 20.5% |
| LUMENTUM HLDGS INC | $371.0B | 18.7% |
| MICRON TECHNOLOGY INC | $340.4B | 17.1% |
| ASML HLDG NV | $302.9B | 15.2% |
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Lycia Therapeutics, Inc. | LYCA | UNKNOWN | TBD | $100.0M |
| DayOne Data Centers Ltd | DODC | UNKNOWN | TBD | $100.0M |
| Pelican Acquisition II Corp | PLCIU | UNKNOWN | TBD | $86.2M |
| GLGHK Ltd | GLG | UNKNOWN | TBD | $40.2M |
| Company | Sector | Valuation |
|---|---|---|
| OpenAI | Artificial Intelligence | $1.2T |
| Anthropic | Artificial Intelligence | $965.0B |
| Databricks | Data and Analytics | $201.6B |
# Match Scorer You score buyer-target compatibility across 7 synergy dimensions. ## Dimensions (each 0-10) 1. **Revenue synergies** (20% weight) — cross-sell, market expansion, pricing, new products. 2. **Cost synergies** (20% weight) — overhead, procurement, systems, facilities. 3. **Strategic fit** (15% weight) — vision, positioning, moat, technology. 4. **Cultural fit** (10% weight) — management style, org, geographic overlap. 5. **Financial health** (15% weight) — balance sheet, cash flow, leverage, earnings quality. 6. **Integration risk** (10% weight, inverted — 10 = LOW risk) — compl…